Ramona M. Lloyd

General Counsel at OPTINOSEPAR

Health Technology

Consumer Services

Profile

Ramona M.
Lloyd is currently Vice President-Regulatory Affairs & Quality at OptiNose, Inc. since 2014.
Former positions include Director-Regulatory Affairs & Quality at Sanofi, Vice President-Regulatory Affairs at Bristol Myers Squibb Co., Senior Vice President-Regulatory Affairs & Safety at ImClone LLC from 2009 to 2010, Vice President-Regulatory Affairs at Johnson & Johnson, and Vice President-Regulatory Affairs at Omthera Pharmaceuticals, Inc. from 2011 to 2012.
Education includes undergraduate studies at the University of Massachusetts and a doctorate from Robert Wood Johnson Medical School.

Ramona M. Lloyd active positions

Companies	Position	Start
OPTINOSEPAR	General Counsel	11/06/2014

All active positions of Ramona M. Lloyd

Former positions of Ramona M. Lloyd

Companies	Position	End
Omthera Pharmaceuticals, Inc. Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia	General Counsel	31/12/2011
ImClone LLC ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer	General Counsel	31/12/2009
SANOFI	General Counsel	-
JOHNSON & JOHNSON	General Counsel	-
BRISTOL-MYERS SQUIBB COMPANY	General Counsel	-

See the detail of Ramona M. Lloyd's experience

Education of Ramona M. Lloyd

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ramona M. Lloyd's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
ImClone LLC ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer	Health Technology
Johnson & Johnson Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products	Health Technology
Sanofi Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines	Health Technology
Omthera Pharmaceuticals, Inc. Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia	Health Technology
OptiNose, Inc. OptiNose, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for patients treated by ear, nose, throat and allergy diseases	Health Technology
University of Massachusetts University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Robert Wood Johnson Medical School Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services